ClinicalTrials.Veeva

Menu

TRanscriptomic Analysis of Circulating Endothelial Cells During Sepsis - TRACES Study

A

Assistance Publique - Hôpitaux de Paris

Status

Not yet enrolling

Conditions

Critical Illness With or Without Sepsis

Treatments

Other: Observational study

Study type

Observational

Funder types

Other

Identifiers

NCT04841824
APHP201060

Details and patient eligibility

About

Vascular dysfunction is an important mechanism involved in organ failure, in the setting of sepsis condition, with different types of circulating endothelial cells.Transcriptom analysis via RNAseq in different types of circulating endothelial cells, comapring critically ill patients with or without sepsis will allow determining differential gene expression for signal pathways in endothelial alteration and restoration associated with sepsis.

Enrollment

1,000 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age between 18 and 85 years
  • Admission in intensive care with or without sepsis
  • Health insurance as per the national insurance system
  • Informed and unopposed patient for participation (or referend closed one)

Exclusion criteria

  • Patient under legal protection
  • Patient under national medical help system
  • Pregnancy

Trial design

1,000 participants in 2 patient groups

Critically ill patients with sepsis
Treatment:
Other: Observational study
Critically ill patients without sepsis

Trial contacts and locations

1

Loading...

Central trial contact

Lara Zafrani, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems